Clinical Imaging Steering Committee Roster
The Clinical Imaging Steering Committee (CISC) serves as a forum for the extramural imaging and oncology communities to provide strategic input to the NCI regarding its significant investment in imaging activities in clinical trials. It provides valuable imaging expertise for other steering committees' evaluations of therapeutic concepts and discussions that include an imaging component. The CISC's membership comprises NCTN group representatives, NCI-funded consortia representatives, community oncologists, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-chairs
Mark A. Rosen, M.D., Ph.D.
University of Pennsylvania
Philadelphia, PA
Heiko Schoder, M.D., M.B.A.
Memorial Sloan Kettering Cancer Center
New York, NY
Members
Carole Baas, Ph.D.
Alamo Breast Cancer Foundation
Southlake, TX
Benjamin Ellingson, Ph.D., M.S.
UCLA Brain Research Institute
Los Angeles, CA
Constantine A. Gatsonis, M.D.
Brown University
Providence, RI
Nathan C. Hall, M.D., Ph.D.
University of Pennsylvania
Philadelphia, PA
Mukesh G. Harisinghani, M.D.
Massachusetts General Hospital
Boston, MA
Thomas A. Hope, M.D.
University of California San Francisco
San Francisco, CA
Heather Alison Jacene, M.D.
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Boston, MA
Michael V. Knopp, M.D., Ph.D.
University of Cincinnati College of Medicine
Cincinnati, OH
Douglas Lake, M.D.
McFarland Clinic
Ames, IA
Michael LeBlanc, Ph.D.
Fred Hutchinson Cancer Research Center
Seattle, WA
Esther H. Lim, M.D., M.B.A.
National Cancer Institute
Bethesda, MD
Frank Lin, M.D.
National Cancer Institute
Bethesda, MD
Michael McDonald, M.D.
National Cancer Institute
Bethesda, MD
Jeff M. Michalski, M.D., M.B.A.
Washington University School of Medicine
St. Louis, MO
Akiva Mintz, M.D., Ph.D.
Columbia University Irving Medical Center
New York, NY
Margaret M. Mooney, M.D., M.B.A.
National Cancer Institute
Bethesda, MD
Nancy A. Obuchowski, Ph.D., M.S.
Cleveland Clinic Foundation
Cleveland, OH
Jane Perlmutter, Ph.D., M.B.A.
Gemini Group
Ann Arbor, MI
Mitchell D. Schnall, M.D.
University of Pennsylvania
Philadelphia, PA
Lawrence Schwartz, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY
Lalitha K. Shankar, M.D., Ph.D.
National Cancer Institute
Bethesda, MD
Marilyn Siegel, M.D.
Washington University
St. Louis, MO
Sharon G. Siegel, M.D.
Maine Medical Center
Portland, ME
Pedro A. Torres-Saavedra, Ph.D.
National Cancer Institute
Bethesda, MD
Alexander Towbin, M.D.
Cincinnati Children's Hospital
Cincinnati, OH
Gilbert Vezina, M.D.
Children's National Medical Center
Washington, DC
Chadwick Wright, M.D., Ph.D.
University of Cincinnati College of Medicine
Cincinnati, OH
Ying Xiao, Ph.D.
University of Pennsylvania
Philadelphia, PA
Martin Yaffe, Ph.D.
Sunnybrook Health Sciences Centre
Toronto, ON, Canada
Jeffrey T. Yap, Ph.D.
University of Utah School of Medicine
Salt Lake City, UT
Ivan Yeung, Ph.D., M.Sc.
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada
Tina Young-Poussaint, M.D., FACR
Children's Hospital Boston
Boston, MA
NCI CCCT Program Director (Interim)
Steven Reeves, Ph.D.
steven.reeves@nih.gov